Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
What short-term side effects should I expect after a lumbar epidural steroid injection?
Executive Summary
A lumbar epidural steroid injection (ESI) commonly causes mild, short‑lived effects such as injection‑site soreness, a transient increase in pain called a “pain flare,” facial flushing, insomnia or sleep disturbance, and temporary elevation of blood glucose; most of these resolve within a few days without treatment [1] [2] [3]. Serious complications — infection, bleeding, dural puncture with persistent headache, nerve injury, or very rarely paralysis — are acknowledged across sources as uncommon but clinically important, and patients are advised to seek prompt care for severe symptoms such as fever, worsening neurologic deficit, or loss of bladder/bowel control [4] [5] [6].
1. What patients are told up front — the routine short‑term effects that are expected and benign
Clinical summaries consistently list a cluster of self‑limited reactions that occur in the first hours to days after an ESI: local soreness at the injection site, numbness or tingling from the local anesthetic, temporary worsening of usual pain for one to three days (a “pain flare”), facial flushing or “steroid flush,” and transient sleep disturbances or increased energy [1] [2] [3]. Multiple sources published between 2019 and 2025 emphasize the time course: most effects are short‑lived, typically resolving within 24–72 hours, and the therapeutic benefit often takes up to one to two weeks to appear [1] [5] [2]. Providers commonly advise rest, ice for soreness, and routine follow‑up calls the day after the procedure to monitor these expected reactions [5].
2. The metabolic and systemic reactions clinicians warn about — why monitoring matters
Beyond local reactions, several sources note systemic steroid effects that can appear briefly after an ESI: facial flushing, water retention, transient increases in blood sugar, menstrual irregularities, anxiety, and insomnia [2] [3] [4]. Johns Hopkins [7] specifically lists menstrual changes and water retention among well‑documented short‑term steroid effects and flags blood sugar elevation as relevant for patients with diabetes [2]. The clinical implication is that patients with diabetes, uncontrolled hypertension, or active infections need tailored counseling, and clinicians often monitor glucose or advise temporary medication adjustments when appropriate [2] [4].
3. Rare but serious complications — what multiple sources consistently flag as red flags
All analyses highlight that serious complications are rare but require urgent attention: infection at the injection site progressing to epidural abscess, bleeding particularly in anticoagulated patients, dural puncture causing severe post‑dural puncture headache, nerve injury, and in extreme cases paralysis or catastrophic neurologic deficit [4] [6] [8]. Sources from 2020 through 2025 stress the same triage thresholds: seek immediate care for high fever, progressive numbness/weakness, loss of bladder or bowel control, or severe unrelenting headache [4] [6]. The consistent messaging across institutions underscores that while these outcomes are uncommon, their consequences justify low thresholds for clinical reassessment [4] [8].
4. Practical recovery guidance — precautions and timelines patients are given
Post‑procedure advice converges: avoid driving or operating heavy machinery for 24 hours if sedation was used, avoid soaking in baths or lakes for 24 hours to reduce infection risk, and limit heavy lifting or strenuous activity until follow‑up [5] [3]. Multiple sources note that pain relief may be delayed up to 7–10 days, and patients may experience a temporary increase in pain for the first 48–72 hours before improvement [5] [1]. Clinics commonly perform a next‑day check‑in call to screen for adverse effects and to reinforce return‑precautions; this standardized follow‑up reflects a balance between the low overall risk profile and the small but serious complications that require prompt recognition [5] [6].
5. Where guidance differs and why it matters — variations in emphasis and possible agendas
Differences among sources center on emphasis rather than contradiction: institutional patient‑education pages (e.g., Johns Hopkins, 2019) and clinic handouts emphasize metabolic and menstrual effects and counseling for chronic conditions [2], whereas recovery‑focused summaries and pain clinics (2023–2025) stress activity restrictions and monitoring for pain flares [8] [3]. The variation reflects different audiences—academic centers highlighting systemic steroid physiology, clinics focusing on practical recovery steps. No source disputes the core profile of short‑term side effects, but readers should note that older institutional pages may list rarer catastrophic risks more prominently to inform consent, while more recent recovery guides offer pragmatic timelines and typical symptom durations [2] [3].
6. Bottom line for patients — what to expect and what to watch for
Expect mild local soreness, possible transient worsening of pain for 1–3 days, facial flushing, sleep changes, and transient blood sugar elevation, with most effects resolving within a few days and therapeutic benefit often appearing over 1–2 weeks [1] [2] [5]. Be vigilant for red‑flag symptoms — high fever, increasing redness or swelling at the site, progressive weakness or numbness, loss of bladder/bowel control, or severe persistent headache — and contact emergency services or your provider immediately if these occur, because although serious complications are rare, they require urgent intervention [4] [6].